Isoleucine Valsartan(137862-78-3)
- Name: Isoleucine Valsartan
- Synonyms:ISB V;Isoleucine Valsartan;
- Molecular Formula:C25H31N5O3
- Molecular Weight:449.54500
- CAS Registry Number:137862-78-3
- EINECS:
- Melting Point:>96oC (dec.)
- Water Solubility:
Other Product
- 137861-93-9/2-Furancarboxylic acid, 2-[4-[[(4-chlorophenoxy)acetyl]amino]-3-oxo-2-isoxazolidinyl]tetrahydro-, monosodium salt
- 137861-94-0/2-Furancarboxylic acid, tetrahydro-2-[4-[[(4-methylphenyl)acetyl]amino]-3-oxo-2-isoxazolidinyl]-5 -oxo-, monosodium salt
- 137861-97-3/2-Furancarboxylic acid, tetrahydro-5-oxo-2-[3-oxo-4-[[(2-oxo-1-imidazolidinyl)carbonyl]amino]-2 -isoxazolidinyl]-, monosodium salt
- 137861-98-4/2-Furancarboxylic acid, tetrahydro-5-oxo-2-[3-oxo-4-[(phenoxyacetyl)amino]-2-isoxazolidinyl]-, (4-nitrophenyl)methyl ester
- 137862-14-7/Glycine, N-[(phenylmethoxy)carbonyl]-, 1-methylenepentyl ester
- 137862-23-8/Ethenamine, 2-ethoxy-2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-N,N-dimethyl-, (Z)-
- 137862-26-1/Cyanamide, (triphenylphosphoranylidene)-, monohydrobromide
- 137862-40-9/Phosphorous acid, phenyl bis(trimethylsilyl) ester
- 137862-55-6/L-Valine, N-(ethoxycarbonyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- 137862-56-7/Cyclohexanecarboxylic acid, 1-[(1-oxopentyl)[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]amino]-
- 137862-57-8/Alanine Valsartan
- 137862-58-9/Pentanamide, N-(2-hydroxyethyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- 137862-59-0/Pentanamide, N-[(1-ethoxycyclopentyl)methyl]-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4- yl]methyl]-
- 137862-67-0/L-Valine, N-(1-oxo-4-pentenyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- 137862-68-1/Glycine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- 137862-69-2/L-Alanine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, methyl ester
- 137862-70-5/Phenylalanine, 4-fluoro-N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]meth yl]-
- 137862-71-6/Phenylalanine, 4-fluoro-N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]meth yl]-, methyl ester
- 137862-77-2/D-Alanine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- 137862-78-3/Isoleucine Valsartan
- 137862-79-4/L-Isoleucine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, methyl ester
- 137862-82-9/L-Alanine, N-(1-oxohexyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- 137862-83-0/L-Alanine, N-(1-oxobutyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- 137862-84-1/Butanoic acid, 2-[(1-oxopentyl)[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]amino]-
- 137862-85-2/Cyclohexanepropanoic acid, a-[(1-oxopentyl)[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]amino]-, (S)-
- 137862-86-3/Cyclohexanepropanoic acid, a-[(1-oxopentyl)[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]amino]-, methyl ester, (S)-
- 137862-88-5/Pentanamide, N-(2-methoxyethyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- 137862-90-9/Pentanamide, N-[3-(phenylmethoxy)propyl]-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl] methyl]-
- 137862-91-0/Pentanamide, N-(3-hydroxypropyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- 137862-93-2/b-Alanine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-